Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC‐free cirrhotic patients undergoing large volume paracentesis
暂无分享,去创建一个
J. Franklin | U. Töx | H. Steffen | A. Bowe | D. Nierhoff | V. Hoffmann | F. Kütting | M. Demir | A. Pelc | Jens Schubert
[1] Hassan Khaled Hamdy,et al. Comparison of Midodrine and Albumin in the Prevention of Paracentesis-induced Circulatory Dysfunction in Cirrhotic Patients: A Randomized Pilot Study , 2014, Journal of clinical gastroenterology.
[2] G. Garcia‐Tsao,et al. The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] P. Caraceni,et al. Albumin infusion in patients undergoing large‐volume paracentesis: A meta‐analysis of randomized trials , 2012, Hepatology.
[4] E. Ierardi,et al. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives. , 2011, Current drug safety.
[5] B. Wang,et al. [Progress in the diagnosis and treatment of ascites in cirrhosis: introduction of EASL clinical practice guidelines on management of ascites in cirrhosis]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[6] P. Ginès,et al. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. , 2010, Journal of hepatology.
[7] G. Nasr,et al. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites , 2010, Journal of cardiovascular disease research.
[8] Kristian Thorlund,et al. Clinical Epidemiology Dovepress , 2022 .
[9] E. E. Abdel-Khalek,et al. Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis , 2010 .
[10] D. García-Compeán,et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. , 2008, Liver.
[11] F. Lammert,et al. Prevention of paracentesis‐induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[12] A. Bhalla,et al. Midodrine Versus Albumin in the Prevention of Paracentesis-Induced Circulatory Dysfunction in Cirrhotics: A Randomized Pilot Study , 2008, The American Journal of Gastroenterology.
[13] Z. Mareček,et al. The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study. , 2007, Hepato-gastroenterology.
[14] P. Angeli,et al. Hyponatremia in cirrhosis: Results of a patient population survey , 2006, Hepatology.
[15] A. Bhalla,et al. Noradrenaline and albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: a randomized pilot study , 2006, Journal of internal medicine.
[16] E. Cholongitas,et al. Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? , 2006, Journal of gastroenterology and hepatology.
[17] I. Durand-zaleski,et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[18] C. K. Nain,et al. Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study , 2006, Journal of gastroenterology and hepatology.
[19] G. Martin,et al. Albumin: Biochemical properties and therapeutic potential , 2005, Hepatology.
[20] E. Ricart,et al. Randomized trial comparing albumin and saline in the prevention of paracentesis‐induced circulatory dysfunction in cirrhotic patients with ascites , 2003, Hepatology.
[21] Douglas G. Altman,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[22] T W Evans,et al. Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure , 2002, Alimentary pharmacology & therapeutics.
[23] M. Foschi,et al. Update on ascites and hepatorenal syndrome. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] T. Asselah,et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study , 2002, Gut.
[25] L. Molina,et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. , 1998, Journal of hepatology.
[26] D. Roulot,et al. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis , 1998, European journal of gastroenterology & hepatology.
[27] W. Jiménez,et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. , 1997, Gastroenterology.
[28] W. Jiménez,et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. , 1996, Gastroenterology.
[29] W. Jiménez,et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. , 1995, Hepatology.
[30] J. Hoofnagle,et al. Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.
[31] R. Terg,et al. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. , 1992, Journal of hepatology.
[32] S. Badalamenti,et al. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites , 1991, Hepatology.
[33] J. Llach,et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. , 1990, Gastroenterology.
[34] J. Llach,et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. , 1988, Gastroenterology.
[35] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[36] G. D’Amico,et al. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.
[37] J. Daurès,et al. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. , 2002, Annals of hepatology.
[38] X. Li,et al. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis. , 2000, Chinese medical journal.
[39] J. M. Hernández López,et al. [Massive paracentesis and administration of dextran 70 vs albumin in cirrhotic patients with tense ascites]. , 1995, Revista de gastroenterologia de Mexico.